Home › Myelofibrosis › North Carolina › Charlotte
Myelofibrosis clinical trials in Charlotte, NC
4 studies for Myelofibrosis are looking for participants at sites in and around Charlotte (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
RecruitingPhase 2
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
RecruitingPhase 1
- Levine Cancer Institute, Charlotte
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- Levine Cancer Institute, Charlotte
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
RecruitingPhase 3
- Atrium Health Levine Cancer Institute, Charlotte
Myelofibrosis trials in other cities
- Houston, TX19 studies
- New York City, NY18 studies
- Boston, MA12 studies
- Durham, NC12 studies
- Seattle, WA11 studies
- Columbus, OH11 studies
- Salt Lake City, UT10 studies
- Miami, FL10 studies
- Baldwin Park, CA9 studies
- Nashville, TN9 studies
- Atlanta, GA9 studies
- Tampa, FL9 studies
Other studies in Charlotte
- Cancer (all types)27 studies
- Breast Cancer22 studies
- Multiple Myeloma21 studies
- Non-Small Cell Lung Cancer19 studies
- Acute Myeloid Leukemia16 studies
- Obesity16 studies
- Overweight15 studies
- Colorectal Cancer13 studies
- Ovarian Cancer12 studies
- Heart Failure11 studies
- Metastatic Cancer11 studies
- Head and Neck Squamous Cell Carcinoma10 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.